You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fosamprenavir

Showing 1 - 25 of 75
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Laryngopharyngeal Reflux Trial in Milwaukee (Lexiva)

Not yet recruiting
  • Laryngopharyngeal Reflux
  • Milwaukee, Wisconsin
    Ally Lesnick
Apr 2, 2022

HIV Trial in Nijmegen (fosamprenavir/ritonavir, olanzapine)

Completed
  • HIV Infections
  • Nijmegen, Netherlands
    CRCN, Radboud Universtity Nijmegen Medical Centre
Nov 26, 2020

HIV Infection, Fungal Infection Trial in Nijmegen (Posaconazole, Fosamprenavir, Ritonavir)

Completed
  • HIV Infection
  • Fungal Infection
  • Nijmegen, Gelderland, Netherlands
    Radboud University Nijmegen Medical Centre
Nov 9, 2020

HIV Trial in United States (Fosamprenavir, Lopinavir/Ritonavir, Ritonavir)

Completed
  • HIV Infections
  • Fosamprenavir
  • +3 more
  • Los Angeles, California
  • +12 more
Oct 28, 2021

HIV Trial in Puerto Rico, United States (lopinavir/ritonavir, indinavir sulfate, tenofovir disoproxil fumarate)

Completed
  • HIV Infections
  • Los Angeles, California
  • +13 more
Oct 28, 2021

(APR): Multi-sponsor Registry to Detect Any Major Teratogenic

Recruiting
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • Any Antiretroviral Therapy
  • Wilmington, North Carolina
    GSK Investigational Site
Oct 4, 2021

Antiretroviral Drugs and Related Drugs During and After

Completed
Has Results
  • HIV Infections
  • Birmingham, Alabama
  • +61 more
Jun 28, 2022

Antiretroviral Agents in HIV-infected Pregnant Women.

Recruiting
  • HIV Infections
    • Brussels, Belgium
    • +20 more
    Nov 28, 2022

    IMPAACT P1080: Psychiatric and Antiretroviral Medication

    Completed
    • ADHD
    • HIV
      • Birmingham, Alabama
      • +21 more
      Jul 30, 2021

      HIV-1-infection Trial (Bictegravir, Lenacapavir, BIC/LEN FDC)

      Not yet recruiting
      • HIV-1-infection
      • (no location specified)
      Aug 12, 2022

      Infection, Human Immunodeficiency Virus I Trial in Puerto Rico, United States (Fosamprenavir)

      Completed
      • Infection, Human Immunodeficiency Virus I
      • Fosamprenavir
      • Beverly Hills, California
      • +51 more
      Apr 16, 2018

      HIV Trial in Puerto Rico, United States (NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT), NNRTIs (EFV, NVP), PIs

      Completed
      Has Results
      • HIV Infections
      • NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT)
      • +2 more
      • Alhambra, California
      • +30 more
      Nov 3, 2021

      HIV Trial in Spain (Nevirapine, Efavirenz, Indinavir/ritonavir)

      Completed
      • HIV Infections
      • Badalona, Barcelona, Spain
      • +5 more
      Dec 3, 2019

      HIV Trial in France (triple therapy, dual therapy)

      Completed
      • HIV
      • triple therapy
      • dual therapy
      • Caen, France
      • +15 more
      Nov 30, 2018

      PENTA Fosamprenavir Study

      Completed
      • Infection, Human Immunodeficiency Virus
      • Exposure to licensed dose of FPV (+/- 20% of 18mg/kg BID + RTV)
      • (no location specified)
      May 31, 2017

      HIV Trial in United States (ATV/r, DRV/r)

      Completed
      Has Results
      • HIV Infections
      • Phoenix, Arizona
      • +10 more
      Jul 18, 2017

      HIV-1 Infection Trial in Worldwide (E/C/F/TAF, TDF, FTC)

      Completed
      Has Results
      • HIV-1 Infection
      • Brussels, Belgium
      • +34 more
      Feb 18, 2020

      ART First-line Treatment Durability in Russia

      Unknown status
      • HIV-1-infection
      • Antiretroviral/Anti HIV
      • Irkutsk, Russian Federation
      • +3 more
      Jan 31, 2020

      HIV-1 Infection Trial in Worldwide (E/C/F/TAF)

      Completed
      Has Results
      • HIV-1 Infection
      • Fort Pierce, Florida
      • +20 more
      Jul 9, 2020

      HIV Trial in Worldwide (DTG 50 mg, RPV 25 mg, CAR)

      Active, not recruiting
      Has Results
      • HIV Infections
      • DTG 50 mg
      • +2 more
      • Long Beach, California
      • +64 more
      Dec 3, 2021

      HIV Trial in Worldwide (DTG 50 mg, RPV 25 mg, CAR)

      Active, not recruiting
      Has Results
      • HIV Infections
      • DTG 50 mg
      • +2 more
      • Bakersfield, California
      • +61 more
      Dec 3, 2021

      HIV-1 Trial in Barcelona (Dolutegravir, PI, 2 NRTI)

      Completed
      • HIV-1
      • Barcelona, Spain
        Hospital Universitari Vall d'Hebron
      Jun 13, 2017

      Infections, Human Immunodeficiency Virus and Herpesviridae Trial in Buffalo (GSK1349572, Fosamprenavir, Ritonavir)

      Completed
      • Infections, Human Immunodeficiency Virus and Herpesviridae
      • Buffalo, New York
        GSK Investigational Site
      Jan 17, 2017

      Infection, Human Immunodeficiency Virus I, HIV Infection Trial in Italy, United States (No intervention; Observational study)

      Completed
      • Infection, Human Immunodeficiency Virus I
      • HIV Infection
      • No intervention; Observational study
      • Fort Lauderdale, Florida
      • +6 more
      May 25, 2017

      HIV Trial in Worldwide (Cabotegravir Tablets, Rilpivirine Tablets, Cabotegravir Injectable Suspension)

      Active, not recruiting
      Has Results
      • HIV Infections
      • Cabotegravir Tablets
      • +3 more
      • Birmingham, Alabama
      • +118 more
      Jul 14, 2021